erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Leontiadou F et al. Thermus thermophilus L4 ribosomal protein: purification and sensitivity alteration against erythromycin of E. coli cells harboring a single amino acid mutant of TthL4 within its extended loop. 2007 Amino Acids pmid:17048124
Levi GC [Macrolide antibiotics--a return in sight?]. 1991 Jul-Sep AMB Rev Assoc Med Bras pmid:1668544
Klug WA and Capelhuchnik P [Preparation of the color for surgery with neomycin and erythromycin]. 1981 AMB Rev Assoc Med Bras pmid:6977148
Bastos-Ceneviva MP [Adverse effects of antibiotics]. 1984 Nov-Dec AMB Rev Assoc Med Bras pmid:6398884
STAHLMAN MT and DENNY FW The prophylaxis of streptococcal infections in patients with rheumatic fever; a comparison between sulfadiazine and erythromycin. 1959 AMA J Dis Child pmid:13660627
WOLF RL and BROWN LT Primary atypical nonbacterial pneumonia; an evaluation of the efficacy of antibiotic therapy in one hundred eighteen cases. 1956 AMA Arch Intern Med pmid:13312701
GOLD H Anthrax; a report of one hundred seventeen cases. 1955 AMA Arch Intern Med pmid:13248274
WAISBREN BA Antibiotic treatment of bacterial endocarditis due to enterococcus: presentation of a case in vitro studies that show a potentiating effect of erythromycin, chlortetracycline, and streptomycin on some strains of enterococci. 1954 AMA Arch Intern Med pmid:13206462
ROANTREE RJ and RANTZ LA Fatal staphylococcal endocarditis treated with erythromycin; rapid development of resistance in vivo and in vitro. 1955 AMA Arch Intern Med pmid:13227653
BUNN PA and COOK E Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin). 1953 AMA Arch Intern Med pmid:13091455
KIRBY WM et al. Treatment of staphylococcic infections with erythromycin. 1953 AMA Arch Intern Med pmid:13091463
SHOEMAKER EH and YOW EM Clinical evaluation of erythromycin. 1954 AMA Arch Intern Med pmid:13123564
WADDINGTON WS et al. Treatment of bacterial pneumonia with erythromycin. 1954 AMA Arch Intern Med pmid:13137631
ROBINSON HM et al. Erythromycin in treatment of dermatoses; report on 1,695 patients. 1954 AMA Arch Derm Syphilol pmid:13188466
MONTGOMERY CH and KNOX JM Erythromycin in the treatment of early syphilis; a preliminary report. 1959 AMA Arch Derm pmid:13669748
Goswami SK et al. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. 1990 Am. Rev. Respir. Dis. pmid:2404441
Mukae H et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. 1993 Am. Rev. Respir. Dis. pmid:8103656
Ichikawa Y et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. 1992 Am. Rev. Respir. Dis. pmid:1626803
Parker MM et al. Unresponsiveness of Legionella bozemanii pneumonia to erythromycin administration despite in vitro sensitivity. 1983 Am. Rev. Respir. Dis. pmid:6638688
Datta JS and Raff MJ Actinomycotic pleuropericarditis. 1974 Am. Rev. Respir. Dis. pmid:4277986
Reisz G et al. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis. 1983 Am. Rev. Respir. Dis. pmid:6846940
Kadota J et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. 1993 Am. Rev. Respir. Dis. pmid:8420410
Pachon J et al. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. 1990 Am. Rev. Respir. Dis. pmid:2382902
Heifets LB et al. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. 1992 Am. Rev. Respir. Dis. pmid:1532486
Ruf B et al. Acquired resistance of MAI to clarithromycin. 1992 Am. Rev. Respir. Dis. pmid:1533999
Kuperman AS and Fernandez RB Subacute staphylococcal pneumonia. 1970 Am. Rev. Respir. Dis. pmid:5410079
Finland M Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia. The 1979 J. Burns Amberson lecture. 1979 Am. Rev. Respir. Dis. pmid:39481
Chemoprophylaxis of chronic bronchitis. A statement by the Committee on Therapy. 1971 Am. Rev. Respir. Dis. pmid:5125186
Davis SD et al. Disseminated osteomyelitis due to "Battey" mycobacteria. 1966 Am. Rev. Respir. Dis. pmid:5908093
Sakata K et al. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. 1993 Am. Rev. Respir. Dis. pmid:8214925
Edelstein PH et al. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. 1984 Am. Rev. Respir. Dis. pmid:6333840
Nelson S et al. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. 1987 Am. Rev. Respir. Dis. pmid:3314615
Srinivasan G et al. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. 1981 Am. Rev. Respir. Dis. pmid:7235378
Hahn D Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. 1993 Am. Rev. Respir. Dis. pmid:8466109
Timberger RJ and Armstrong D Ornithosis without direct bird exposure: response to erythromycin. Report of a case. 1969 Am. Rev. Respir. Dis. pmid:5815139
Dautzenberg B et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. 1991 Am. Rev. Respir. Dis. pmid:1832527
Doyle WM et al. Pulmonary disease caused by Mycobacterium xenopei. 1968 Am. Rev. Respir. Dis. pmid:5647216
HALLETT WY et al. Chemoprophylaxis in chronic obstructive pulmonary emphysema: a twelve-week study with erythromycin. 1959 Am. Rev. Respir. Dis. pmid:14399110
Lakritz J et al. Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals. 1997 Am. J. Vet. Res. pmid:8989497
Lester GD et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. 1998 Am. J. Vet. Res. pmid:9522953
Palmer JE and Benson CE Effect of treatment with erythromycin and rifampin during the acute stages of experimentally induced equine ehrlichial colitis in ponies. 1992 Am. J. Vet. Res. pmid:1466503
Stalheim OH Chemotherapy of renal leptospirosis in hamsters. 1966 Am. J. Vet. Res. pmid:4164020
Lakritz J et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. 2000 Am. J. Vet. Res. pmid:10951982
Lakritz J et al. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. 2000 Am. J. Vet. Res. pmid:10976728
Lakritz J et al. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. 1999 Am. J. Vet. Res. pmid:10211682
Afshari GR et al. Effect of parenteral administration of ivermectin and erythromycin on abomasal emptying rate in suckling calves. 2009 Am. J. Vet. Res. pmid:19335110
Libal MC Comparison of minimal inhibitory concentration and disk-diffusion antimicrobic sensitivity testing of bacterial pathogens isolated from food animals. 1985 Am. J. Vet. Res. pmid:3159322
Cooper RF et al. Characterization of Listeria monocytogenes serotype 5. 1973 Am. J. Vet. Res. pmid:4198346
Koenig JB et al. Effect of intraluminal distension or ischemic strangulation obstruction of the equine jejunum on jejunal motilin receptors and binding of erythromycin lactobionate. 2006 Am. J. Vet. Res. pmid:16649915
Smith JA et al. Inhibitory and lethal activities of rosaramicin, erythromycin, and clindamycin against Campylobacter fetus subsp jejuni and intestinalis. 1983 Am. J. Vet. Res. pmid:6625312